Fig. 6: Pam3CSK4 modulates the preterm female immune response.

Serum IL-1β (a), IL-18 (b), IL-1RA (c) and IL-33 (d) levels in pam3CSK4-treated male (n = 22) and female (n = 18) preterm neonates. Values displayed represent mean + standard deviation of pg/ml. *=significant at p < 0.05.